Aptamer-Conjugated Multi-Quantum Dot-Embedded Silica Nanoparticles for Lateral Flow Immunoassay
Biosensors · 2025
DOI: 10.3390/bios15010054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2025. Verfasst von Kwanghee Yoo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea. Hauptthemen laut MEDLINE: Quantum Dots, Aptamers, Nucleotide, Biosensing Techniques. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Konkuk Unversity, Konkuk University.
Abstract (Originalsprache)
Lateral flow immunoassays (LFIAs) are widely used for their low cost, simplicity, and rapid results; however, enhancing their reliability requires the meticulous selection of ligands and nanoparticles (NPs). SiO2@QD@SiO2 (QD2) nanoparticles, which consist of quantum dots (QDs) embedded in a silica (SiO2) core and surrounded by an outer SiO2 shell, exhibit significantly higher fluorescence intensity (FI) compared to single QDs. In this study, we prepared QD2@PEG@Aptamer, an aptamer conjugated with QD2 using succinimidyl-[(N-maleimidopropionamido)-hexaethyleneglycol]ester, which is 130 times brighter than single QDs, for detecting carbohydrate antigen (CA) 19-9 through LFIA. For LFIA optimization, we determined the optimal conditions as a 1.0:2.0 × 10−2 ratio of polyethylene glycol (PEG) to aptamer by adjusting the amounts of PEG and aptamer, phosphate-buffered saline containing 0.5% Tween® 20 as a developing solution, and 0.15 μg NPs by setting the NP weight during development. Under these conditions, QD2@PEG@Aptamer selectively detected CA19-9, achieving a detection limit of 1.74 × 10−2 mg·mL−1. Moreover, FI remained stable for 10 days after detection. These results highlight the potential of QD2 and aptamer conjugation technology as a reliable and versatile sensing platform for various diagnostic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea.
- Company of Global Zeus, Hwaseong 18363, Republic of Korea.
- Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
ORCID-Profile: Kwanghee Yoo, Heung Su Jung, Homan Kang, Bong-Hyun Jun
Förderung
- Konkuk Unversity
- Konkuk University
Zitieren
APA
Yoo, K., Cho, H. S., Kim, J., Shin, M., Chu, J. S., Jang, S., Bae, H. J., Jung, H. S., Kang, H., & Jun, B. H. (2025). Aptamer-Conjugated Multi-Quantum Dot-Embedded Silica Nanoparticles for Lateral Flow Immunoassay. Biosensors. https://doi.org/10.3390/bios15010054
Vancouver
Yoo K, Cho HS, Kim J, Shin M, Chu JS, Jang S, et al. Aptamer-Conjugated Multi-Quantum Dot-Embedded Silica Nanoparticles for Lateral Flow Immunoassay. Biosensors. 2025. doi:10.3390/bios15010054
BibTeX
@article{Yoo2025,
author = {Yoo, Kwanghee and Cho, Hye-Seong and Kim, Jaehi and Shin, Minsup and Chu, Jun-Sik and Jang, Sohyeon and Bae, Han-Joo and Jung, Heung Su and Kang, Homan and Jun, Bong-Hyun},
title = {Aptamer-Conjugated Multi-Quantum Dot-Embedded Silica Nanoparticles for Lateral Flow Immunoassay},
journal = {Biosensors},
year = {2025},
doi = {10.3390/bios15010054}
}
EUVIMED